Healthium Medtech Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review
- June 17, 2026
- Posted by: Kunal Singla
- Category: News
Healthium Medtech (NSE:HEALTHIUM) CMP: Rs 220 (2026). Sector: Healthcare Services and Hospitals. JM Financial: Buy Rs 265. ICICI Securities: Neutral Rs 242. Consensus: Rs 254.
The Healthium Medtech stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Healthium Medtech share price prediction as one data point and not as a guarantee of future performance.
This article reviews every dimension of the Healthium Medtech stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.
Click Here – Get Free Investment Predictions
What Analysts Predict for Healthium Medtech Stock in 2026
Analyst consensus on the Healthium Medtech stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and ICICI Securities. All figures are sourced from publicly available research and should be verified before publishing.
| Brokerage | Rating | Healthium Medtech Stock Prediction (Rs) | Updated |
|---|---|---|---|
| JM Financial | Buy | Rs 265 | 2026 |
| ICICI Securities | Neutral | Rs 242 | 2026 |
| Analyst Consensus | — | Rs 254 | 2026 |
The analyst target range for Healthium Medtech reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Healthium Medtech stock forecast from the current price of Rs 220 may or may not be realised by end of 2026.
3 Stocks Building Serious Momentum Right Now
When Univest analysts identify high-conviction stock opportunities, investors pay attention.
Our research team has shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.
- Discover stocks investors are actively accumulating
- High-conviction opportunities backed by research
- Designed for the next phase of market growth
Unlock the latest Top Stock Picks now on Univest
Healthium Medtech Company Overview
Healthium Medtech is a leading healthcare services provider operating hospitals, diagnostics or specialty facilities across India. The Healthium Medtech stock prediction for 2026 reflects structural growth in healthcare demand and operating leverage from bed expansion.
| Metric | Value |
|---|---|
| NSE Ticker | HEALTHIUM |
| Sector | Healthcare Services and Hospitals |
| CMP | Rs 220 (2026) |
| 52 Week High | — |
| 52 Week Low | — |
| Market Cap | — |
| P/E Ratio | — |
| Healthium Medtech Stock Prediction Consensus (12M) | Rs 254 |
Healthium Medtech Stock Prediction by Time Horizon
Analysts split the Healthium Medtech share price prediction across time frames as near-term drivers differ materially from the long-term view.
Short-Term Healthium Medtech Stock Prediction
The near-term Healthium Medtech stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 220 are being watched closely. A short-term Healthium Medtech share price prediction carries the most uncertainty of any time horizon.
12-Month Healthium Medtech Stock Prediction
JM Financial targets Rs 265 (Buy) and ICICI Securities targets Rs 242 (Neutral). Most desks refresh their Healthium Medtech stock forecast within two to four weeks of each quarterly earnings print. The Healthium Medtech share price prediction should be verified against the most recent analyst reports.
Long-Term Healthium Medtech Stock Prediction
The long-term outlook for Healthium Medtech is built on assumptions about demand recovery, margin expansion and revenue diversification in the Healthcare Services and Hospitals sector. Long-term price targets carry the most uncertainty and should be treated as directional guidance only.
Healthium Medtech Stock Forecast: Key Factors
The following four factors appear consistently in analyst research on Healthium Medtech and are the primary inputs into the bull and bear case scenarios.
Bed Addition and Occupancy
Hospital bed additions and occupancy rates are the primary metrics in the Healthium Medtech stock forecast. Analysts look for occupancy above 65 percent as the basis for a higher Healthium Medtech share price prediction.
Revenue per Occupied Bed
Revenue per occupied bed improvement reflects the shift to higher-margin specialties. Analysts revise the Healthium Medtech share price prediction upward when per-bed revenue grows consistently.
EBITDA Margin Maturity
A portfolio shift toward mature hospitals supports the bullish Healthium Medtech stock prediction, while new hospital ramp-ups dilute margins in the near term.
International Patient Revenue
Medical tourism revenue provides premium pricing and diversifies the revenue base, supporting the Healthium Medtech stock forecast and premium valuation.
Healthium Medtech Stock Prediction: Bull and Bear Scenarios
| Scenario | Healthium Medtech Stock Prediction | Key Conditions |
|---|---|---|
| Bull Case | Rs 265 | Strong execution, margin improvement, favourable macro and sector re-rating |
| Base Case | Rs 254 | Steady performance, gradual recovery, margins hold, growth on track |
| Bear Case | Rs 215 | Demand deterioration, margin pressure, sector de-rating and macro headwinds |
The bull case Healthium Medtech stock forecast of Rs 265 assumes most positive variables converge. The base case of Rs 254 is the analyst consensus and may or may not be achieved.
How Analysts Are Reading the Healthium Medtech Stock Story
Analyst reviews of the Healthium Medtech share price prediction highlight the company’s core strengths in Healthcare Services and Hospitals alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the analyst consensus for Healthium Medtech is built on real business strengths set against real risks.
Key Risks to the Healthium Medtech Stock Prediction
New Hospital Ramp-Up Costs
New hospital investments have multi-year ramp-up periods during which margins are diluted. This is a recurring near-term risk to the Healthium Medtech stock prediction.
Regulatory and Price Cap Risk
Government-mandated price caps on medical procedures affect hospital revenues and can compress the Healthium Medtech stock forecast.
Competition
New hospital chains expanding into metro and tier 2 cities create competitive pressure on occupancy and billing, which is a recurring caution in the Healthium Medtech share price prediction.
Medical Cost Inflation
Rising manpower and consumables costs affect EBITDA margins and the Healthium Medtech stock forecast. Cost risk is reflected in the width of the Healthium Medtech share price prediction range.
How to Monitor the Healthium Medtech Stock Forecast
Track the Healthium Medtech share price prediction consensus quarterly. After every earnings release, most brokerages revise their Healthium Medtech stock forecast within two weeks. Comparing the revised analyst target to the previous estimate tells you whether sentiment on Healthium Medtech is improving or deteriorating.
Compare the current price of Rs 220 with the analyst target range of Rs 265 to Rs 242. A wide target band reflects genuine uncertainty on Healthium Medtech, so position size should reflect that range rather than the midpoint alone.
Review the Healthium Medtech share price prediction every quarter against key business metrics for the Healthcare Services and Hospitals sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.
Check Live Healthium Medtech Fundamentals on the Univest Screener
Conclusion
The Healthium Medtech stock prediction for 2026 reflects the analyst community’s assessment of Healthium Medtech’s competitive position, earnings trajectory and macro environment. JM Financial holds a Buy stance with a target of Rs 265 while ICICI Securities has a Neutral rating with a target of Rs 242, giving an analyst consensus of Rs 254.
The Healthium Medtech stock forecast is set against near-term risks that make the Healthium Medtech share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking how the Healthium Medtech share price target changes over time is more valuable than relying on any single estimate.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Download the Univest iOS App or Univest Android App to track live analyst targets, price movements and research updates for Healthium Medtech in real time.
Disclaimer: Data and figures in this article are sourced from publicly available information and may or may not be accurate. Analyst price targets are from public brokerage reports and should be independently verified. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Healthium Medtech Stock Prediction 2026
What is the Healthium Medtech stock prediction for 2026?
Ans. The Healthium Medtech stock prediction for 2026 is based on analyst consensus from JM Financial and ICICI Securities. The consensus target is Rs 254. All estimates may or may not be achieved.
Is the Healthium Medtech stock prediction bullish or bearish?
Ans. JM Financial has a Buy rating with target Rs 265. ICICI Securities has a Neutral rating with target Rs 242. The Healthium Medtech stock forecast reflects genuine analyst diversity of opinion.
What is the Healthium Medtech share price prediction based on fundamentals?
Ans. The Healthium Medtech share price prediction rests on the bed addition pipeline, occupancy trend, revenue per bed and EBITDA margin maturity. Analysts tracking Healthium Medtech closely cite these as the primary drivers of the 2026 outlook.
What is the long-term Healthium Medtech stock prediction?
Ans. The long-term outlook assumes Healthium Medtech sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 254 is the nearest reliable anchor point.
What are the key risks to the Healthium Medtech stock prediction?
Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for Healthium Medtech should be read alongside its risk assumptions.
What does the Healthium Medtech stock forecast say for 2026?
Ans. JM Financial: Buy target Rs 265. ICICI Securities: Neutral target Rs 242. These Healthium Medtech share price prediction estimates may or may not prove accurate.
Where can I track the latest Healthium Medtech stock prediction?
Ans. Track the latest analyst targets and price movements for Healthium Medtech on the NSE and BSE websites and on the Univest app and screener for live data.
